The health benefits, side effects and risks have been considered in formulating the recommendations.
There is an explicit link between the recommendations and the supporting evidence.
The guideline has been externally reviewed by experts prior to its publication.
A procedure for updating the guideline is provided.
The recommendations are specific and unambiguous.
The different options for management of the condition are clearly presented.
Key recommendations are easily identifiable.
The guideline is supported with tools for application.
The potential organisational barriers in applying the recommendations have been discussed.
The potential cost implications of applying the recommendations have been considered.
The guideline presents key review criteria for monitoring and/or audit purposes.
The guideline is editorially independent from the funding body.
Conflicts of interest of guideline development members have been recorded.